1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Gamma-oryzanol as a possible PPAR-γ agonist in adipose tissue may represents a coadjutant therapeutic to prevent cytokine storm in COVID-19 obese patients
(
- Contribution to journal › Article
- 2018
-
Mark
Gamma Oryzanol Treats Obesity-Induced Kidney Injuries by Modulating the Adiponectin Receptor 2/PPAR-α Axis
(
- Contribution to journal › Article